Pure MHC

Pure MHC, LLC is a discovery and development company with platform technology and expertise in disease-specific (HLA Class I and II) target identification and validation, as well as the development of immunotherapeutic drugs for cancer, infectious diseases, and autoimmune disorders. Pure MHC's mission is to support and enable the creation of new therapies for treating cancer, autoimmunity, and infectious diseases by leveraging the human leukocyte antigen (HLA) system to selectively identify and eliminate diseased cells.